UK’s Sava lands €16.6M to democratise glucose monitoring and advance health…
London-based Sava Technologies, a startup pioneering real-time molecular health monitoring, has secured $19M (approximately €16.6M) in Series A funding led by Balderton Capital and Pentland Ventures.